Abstract
Iron chelation therapy can be used for the selective removal of Fe3+ ions from spiked human plasma by ion imprinting. N-Methacryloyl-(L)-glutamic acid (MAGA) was chosen as the chelating monomer. In the first step, MAGA was complexed with the Fe3+ ions to prepare the precomplex, and then the ion-imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-(L)-glutamic acid) [PHEMAGA-Fe3+] cryogel column was prepared by cryo-polymerization under a semi-frozen temperature of − 12°C for 24 h. Subsequently, the template, of Fe3+ ions was removed from the matrix by using 0.1 M EDTA solution. The values for the specific surface area of the imprinted PHEMAGA-Fe3+ and non-imprinted PHEMAGA cryogel were 45.74 and 7.52 m2/g respectively, with a pore size in the range of 50–200 μm in diameter. The maximum Fe3+ adsorption capacity was 19.8 μmol Fe3+/g cryogel from aqueous solutions and 12.28 μmol Fe3+/g cryogel from spiked human plasma. The relative selectivity coefficients of ion-imprinted cryogel for Fe3+/Ni2+ and Fe3+/Cd2+ were 1.6 and 4.2-fold greater than the non-imprinted matrix, respectively. It means that the PHEMAGA-Fe3+ cryogel possesses high selectivity to Fe3+ ions, and could be used many times without significantly decreasing the adsorption capacity.
Declaration of interest
The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.